F,G,H,I and K crystal forms of imatinib mesylate

Details for Australian Patent Application No. 2011201286 (hide)

Owner Novartis AG

Inventors Mutz, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2011201286

Parent 2006316823

Filing date 22 March 2011

Wipo publication date 7 April 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 April 2011 Application Open to Public Inspection

  Published as AU-A-2011201286

7 April 2011 Complete Application Filed

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application was refused. Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201287-Fiber optic network architecture having optical connection terminals in series arrangement

2011201285-Touch screen liquid crystal display